The FDA's pilot program includes two proof-of-concept clinical trials reporting endpoints and data signals in real time, involving AstraZeneca and Amgen.
- In the news
Statistical Methods in Clinical Trials
Moving in Cancer Discovery.
- Moved, week to 23 Oct 2026
- 1
- Papers in 60 days
- 11
Add Statistical Methods in Clinical Trials as an interest in JClubFree on iPhone and Android · interests shape Home, Discover and your digest
Rebuilt
Moved this week
Latest in Statistical Methods in Clinical Trials
Newest first · last 60 days
Simulation-guided design enhances complex clinical trial planning by evaluating operating characteristics and refining protocols for accelerated drug development.
Harmonizing trial design and biomarker integration is essential to improve personalized treatment for large B-cell lymphoma patients.
Off-target drug repurposing may provide a scalable therapeutic framework for rare cancers lacking canonical targets, with emerging evidence supporting its potential.
- Open access
Add Statistical Methods in Clinical Trials as an interest in JClub
Browse JClub
Journals this month
- bioRxiv6131
- medRxiv1703
- PNAS447
- Sci Adv354
- JAMA262
- Environ Res230
- BMJ182
- Environ Pollution165
- Nat Commun161
- Science141
- Nature138
- Lancet128
- Cell Rep120
- NEJM119
- mBio107
- Plant Cell Environ107
- Curr Biol106
- J Exp Bot106
Topics moving, week to 23 Oct 2026
- Single-cell and spatial transcriptomics6
- Neuroinflammation and Neurodegeneration Mechanisms5
- Bacteriophages and microbial interactions5
- Gut microbiota and health5
- Genomics and Phylogenetic Studies4
- Cancer Genomics and Diagnostics4
- Cancer Immunotherapy and Biomarkers4
- Alzheimer's disease research and treatments3
- Inflammatory Bowel Disease3
- Influenza Virus Research Studies3